Exact Mass: 435.2134264
Exact Mass Matches: 435.2134264
Found 500 metabolites which its exact mass value is equals to given mass value 435.2134264
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vertine
C26H29NO5 (435.20456240000004)
A quinolizidine alkaloid isolated from the flowering plant Heimia salicifolia and exhibits anti-inflammatory properties.
Paxilline
Paxilline is an indole diterpene alkaloid with formula C27H33NO4 isolated from Penicillium paxilli. It is a potent inhibitor of large conductance Ca2(+)- and voltage-activated K(+) (BK)-type channels. It has a role as a mycotoxin, a Penicillium metabolite, an anticonvulsant, an Aspergillus metabolite, a potassium channel blocker, a genotoxin, a geroprotector and an EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor. It is an organic heterohexacyclic compound, a tertiary alcohol, a terpenoid indole alkaloid, an enone and a diterpene alkaloid. Paxilline is a natural product found in Penicillium thiersii, Aspergillus foveolatus, and other organisms with data available. Tremorgenic agent from Penicillium paxilli, Acremonium lorii, Emericella foveolata, Emericella desertorum and Emericella striata Paxilline is a potassium channel blocker. Paxilline is a toxic, tremorgenic indole alkaloid produced by Penicillium paxilli An indole diterpene alkaloid with formula C27H33NO4 isolated from Penicillium paxilli. It is a potent inhibitor of large conductance Ca2(+)- and voltage-activated K(+) (BK)-type channels. Tremorgenic agent from Penicillium paxilli, Acremonium lorii, Emericella foveolata, Emericella desertorum and Emericella striata D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators Paxilline is an indole alkaloid mycotoxin from Penicillium paxilli, acts as a potent BK channels inhibitor by an almost exclusively closed-channel block mechanism. Paxilline also inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) with IC50s between 5 μM and 50 μM for differing isoforms. Paxilline possesses significant anticonvulsant activity[1][2][3].
Fosinoprilat
C23H34NO5P (435.2174484000001)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Valsartan
Valsartan is an angiotensin-receptor blocker (ARB) that may be used to treat a variety of cardiac conditions including hypertension, diabetic nephropathy and heart failure. Valsartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Valsartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].
Cadabicine
C25H29N3O4 (435.21579540000005)
Cadabicine is found in fruits. Cadabicine is an alkaloid from the stem bark of the famine food Cadaba farinosa (luquata sigmama). Alkaloid from the stem bark of the famine food Cadaba farinosa (luquata sigmama). Cadabicine is found in fruits.
14alpha-Hydroxy-4beta-deoxypaxilline
14alpha-Hydroxy-4beta-deoxypaxilline is a metabolite of Penicillium paxilli and Acremonium lolii. Metabolite of Penicillium paxilli and Acremonium lolii
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
Propranolol glucuronide
Trimazosin hydrochloride
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Melemeleone B
C23H33NO5S (435.2079328000001)
A sesquiterpenoid with a quinone and taurine functionality. It is isolated from the sponge Dysidea avara, and exhibits inhibitory activity against tyrosine kinase.
Phenol, 2,2,2-1H-indole-1,2,3-triyltris(methylene))tris-
C29H25NO3 (435.18343400000003)
(1RS,2RS,2aRS,10aSR)-1,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3H-cyclobuta[4,5]pyrano[3,2-c]quinolin-3-one|ARQ500206|euodenine A
C26H29NO5 (435.20456240000004)
Valsartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1075 CONFIDENCE standard compound; INTERNAL_ID 1112 CONFIDENCE standard compound; INTERNAL_ID 8608 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2583 INTERNAL_ID 1112; CONFIDENCE standard compound Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].
Cilazapril Monohydrate
C22H33N3O6 (435.23692380000006)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Paxilline
Paxilline is an indole alkaloid mycotoxin from Penicillium paxilli, acts as a potent BK channels inhibitor by an almost exclusively closed-channel block mechanism. Paxilline also inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) with IC50s between 5 μM and 50 μM for differing isoforms. Paxilline possesses significant anticonvulsant activity[1][2][3].
Ala Ala Phe Gln
Ala Ala Gln Phe
Ala Cys Asp Lys
C16H29N5O7S (435.17876040000004)
Ala Cys Lys Asp
C16H29N5O7S (435.17876040000004)
Ala Cys Arg Ser
C15H29N7O6S (435.18999340000005)
Ala Cys Ser Arg
C15H29N7O6S (435.18999340000005)
Ala Asp Cys Lys
C16H29N5O7S (435.17876040000004)
Ala Asp Lys Cys
C16H29N5O7S (435.17876040000004)
Ala Phe Ala Gln
Ala Phe Gln Ala
Ala Lys Cys Asp
C16H29N5O7S (435.17876040000004)
Ala Lys Asp Cys
C16H29N5O7S (435.17876040000004)
Ala Lys Met Ser
Ala Lys Ser Met
Ala Met Lys Ser
Ala Met Asn Thr
C16H29N5O7S (435.17876040000004)
Ala Met Gln Ser
C16H29N5O7S (435.17876040000004)
Ala Met Ser Lys
Ala Met Ser Gln
C16H29N5O7S (435.17876040000004)
Ala Met Thr Asn
C16H29N5O7S (435.17876040000004)
Ala Asn Met Thr
C16H29N5O7S (435.17876040000004)
Ala Asn Thr Met
C16H29N5O7S (435.17876040000004)
Ala Gln Ala Phe
Ala Gln Phe Ala
Ala Gln Met Ser
C16H29N5O7S (435.17876040000004)
Ala Gln Ser Met
C16H29N5O7S (435.17876040000004)
Ala Arg Cys Ser
C15H29N7O6S (435.18999340000005)
Ala Arg Ser Cys
C15H29N7O6S (435.18999340000005)
Ala Ser Cys Arg
C15H29N7O6S (435.18999340000005)
Ala Ser Lys Met
Ala Ser Met Lys
Ala Ser Met Gln
C16H29N5O7S (435.17876040000004)
Ala Ser Gln Met
C16H29N5O7S (435.17876040000004)
Ala Ser Arg Cys
C15H29N7O6S (435.18999340000005)
Ala Thr Met Asn
C16H29N5O7S (435.17876040000004)
Ala Thr Asn Met
C16H29N5O7S (435.17876040000004)
Cys Ala Asp Lys
C16H29N5O7S (435.17876040000004)
Cys Ala Lys Asp
C16H29N5O7S (435.17876040000004)
Cys Ala Arg Ser
C15H29N7O6S (435.18999340000005)
Cys Ala Ser Arg
C15H29N7O6S (435.18999340000005)
Cys Asp Ala Lys
C16H29N5O7S (435.17876040000004)
Cys Asp Lys Ala
C16H29N5O7S (435.17876040000004)
Cys Glu Gly Lys
C16H29N5O7S (435.17876040000004)
Cys Glu Lys Gly
C16H29N5O7S (435.17876040000004)
Cys Gly Glu Lys
C16H29N5O7S (435.17876040000004)
Cys Gly Lys Glu
C16H29N5O7S (435.17876040000004)
Cys Gly Arg Thr
C15H29N7O6S (435.18999340000005)
Cys Gly Thr Arg
C15H29N7O6S (435.18999340000005)
Cys Ile Asn Ser
C16H29N5O7S (435.17876040000004)
Cys Ile Ser Asn
C16H29N5O7S (435.17876040000004)
Cys Lys Ala Asp
C16H29N5O7S (435.17876040000004)
Cys Lys Asp Ala
C16H29N5O7S (435.17876040000004)
Cys Lys Glu Gly
C16H29N5O7S (435.17876040000004)
Cys Lys Gly Glu
C16H29N5O7S (435.17876040000004)
Cys Lys Ser Val
Cys Lys Val Ser
Cys Leu Asn Ser
C16H29N5O7S (435.17876040000004)
Cys Leu Ser Asn
C16H29N5O7S (435.17876040000004)
Cys Asn Ile Ser
C16H29N5O7S (435.17876040000004)
Cys Asn Leu Ser
C16H29N5O7S (435.17876040000004)
Cys Asn Ser Ile
C16H29N5O7S (435.17876040000004)
Cys Asn Ser Leu
C16H29N5O7S (435.17876040000004)
Cys Asn Thr Val
C16H29N5O7S (435.17876040000004)
Cys Asn Val Thr
C16H29N5O7S (435.17876040000004)
Cys Gln Ser Val
C16H29N5O7S (435.17876040000004)
Cys Gln Val Ser
C16H29N5O7S (435.17876040000004)
Cys Arg Ala Ser
C15H29N7O6S (435.18999340000005)
Cys Arg Gly Thr
C15H29N7O6S (435.18999340000005)
Cys Arg Ser Ala
C15H29N7O6S (435.18999340000005)
Cys Arg Thr Gly
C15H29N7O6S (435.18999340000005)
Cys Ser Ala Arg
C15H29N7O6S (435.18999340000005)
Cys Ser Ile Asn
C16H29N5O7S (435.17876040000004)
Cys Ser Lys Val
Cys Ser Leu Asn
C16H29N5O7S (435.17876040000004)
Cys Ser Asn Ile
C16H29N5O7S (435.17876040000004)
Cys Ser Asn Leu
C16H29N5O7S (435.17876040000004)
Cys Ser Gln Val
C16H29N5O7S (435.17876040000004)
Cys Ser Arg Ala
C15H29N7O6S (435.18999340000005)
Cys Ser Val Lys
Cys Ser Val Gln
C16H29N5O7S (435.17876040000004)
Cys Thr Gly Arg
C15H29N7O6S (435.18999340000005)
Cys Thr Asn Val
C16H29N5O7S (435.17876040000004)
Cys Thr Arg Gly
C15H29N7O6S (435.18999340000005)
Cys Thr Val Asn
C16H29N5O7S (435.17876040000004)
Cys Val Lys Ser
Cys Val Asn Thr
C16H29N5O7S (435.17876040000004)
Cys Val Gln Ser
C16H29N5O7S (435.17876040000004)
Cys Val Ser Lys
Cys Val Ser Gln
C16H29N5O7S (435.17876040000004)
Cys Val Thr Asn
C16H29N5O7S (435.17876040000004)
Asp Ala Cys Lys
C16H29N5O7S (435.17876040000004)
Asp Ala Lys Cys
C16H29N5O7S (435.17876040000004)
Asp Cys Ala Lys
C16H29N5O7S (435.17876040000004)
Asp Cys Lys Ala
C16H29N5O7S (435.17876040000004)
Asp Lys Ala Cys
C16H29N5O7S (435.17876040000004)
Asp Lys Cys Ala
C16H29N5O7S (435.17876040000004)
Asp Lys Ser Ser
C16H29N5O9 (435.19651840000006)
Asp Ser Lys Ser
C16H29N5O9 (435.19651840000006)
Asp Ser Ser Lys
C16H29N5O9 (435.19651840000006)
Glu Cys Gly Lys
C16H29N5O7S (435.17876040000004)
Glu Cys Lys Gly
C16H29N5O7S (435.17876040000004)
Glu Gly Cys Lys
C16H29N5O7S (435.17876040000004)
Glu Gly Lys Cys
C16H29N5O7S (435.17876040000004)
Glu Lys Cys Gly
C16H29N5O7S (435.17876040000004)
Glu Lys Gly Cys
C16H29N5O7S (435.17876040000004)
Phe Ala Ala Gln
Phe Ala Gln Ala
Phe Gly Gly Arg
C19H29N7O5 (435.22300640000003)
Phe Gly Asn Val
Phe Gly Arg Gly
C19H29N7O5 (435.22300640000003)
Phe Gly Val Asn
Phe Asn Gly Val
Phe Asn Val Gly
Phe Gln Ala Ala
Phe Arg Gly Gly
C19H29N7O5 (435.22300640000003)
Phe Val Gly Asn
Phe Val Asn Gly
Gly Cys Glu Lys
C16H29N5O7S (435.17876040000004)
Gly Cys Lys Glu
C16H29N5O7S (435.17876040000004)
Gly Cys Arg Thr
C15H29N7O6S (435.18999340000005)
Gly Cys Thr Arg
C15H29N7O6S (435.18999340000005)
Gly Glu Cys Lys
C16H29N5O7S (435.17876040000004)
Gly Glu Lys Cys
C16H29N5O7S (435.17876040000004)
Gly Phe Gly Arg
C19H29N7O5 (435.22300640000003)
Gly Phe Asn Val
Gly Phe Arg Gly
C19H29N7O5 (435.22300640000003)
Gly Phe Val Asn
Gly Gly Phe Arg
C19H29N7O5 (435.22300640000003)
Gly Gly Arg Phe
C19H29N7O5 (435.22300640000003)
Gly Lys Cys Glu
C16H29N5O7S (435.17876040000004)
Gly Lys Glu Cys
C16H29N5O7S (435.17876040000004)
Gly Lys Met Thr
Gly Lys Thr Met
Gly Met Lys Thr
Gly Met Gln Thr
C16H29N5O7S (435.17876040000004)
Gly Met Thr Lys
Gly Met Thr Gln
C16H29N5O7S (435.17876040000004)
Gly Asn Phe Val
Gly Asn Val Phe
Gly Gln Met Thr
C16H29N5O7S (435.17876040000004)
Gly Gln Thr Met
C16H29N5O7S (435.17876040000004)
Gly Arg Cys Thr
C15H29N7O6S (435.18999340000005)
Gly Arg Phe Gly
C19H29N7O5 (435.22300640000003)
Gly Arg Gly Phe
C19H29N7O5 (435.22300640000003)
Gly Arg Thr Cys
C15H29N7O6S (435.18999340000005)
Gly Thr Cys Arg
C15H29N7O6S (435.18999340000005)
Gly Thr Lys Met
Gly Thr Met Lys
Gly Thr Met Gln
C16H29N5O7S (435.17876040000004)
Gly Thr Gln Met
C16H29N5O7S (435.17876040000004)
Gly Thr Arg Cys
C15H29N7O6S (435.18999340000005)
Gly Val Phe Asn
Gly Val Asn Phe
Ile Cys Asn Ser
C16H29N5O7S (435.17876040000004)
Ile Cys Ser Asn
C16H29N5O7S (435.17876040000004)
Ile Asn Cys Ser
C16H29N5O7S (435.17876040000004)
Ile Asn Ser Cys
C16H29N5O7S (435.17876040000004)
Ile Ser Cys Asn
C16H29N5O7S (435.17876040000004)
Ile Ser Asn Cys
C16H29N5O7S (435.17876040000004)
Lys Ala Cys Asp
C16H29N5O7S (435.17876040000004)
Lys Ala Asp Cys
C16H29N5O7S (435.17876040000004)
Lys Ala Met Ser
Lys Ala Ser Met
Lys Cys Ala Asp
C16H29N5O7S (435.17876040000004)
Lys Cys Asp Ala
C16H29N5O7S (435.17876040000004)
Lys Cys Glu Gly
C16H29N5O7S (435.17876040000004)
Lys Cys Ser Val
Lys Cys Val Ser
Lys Asp Ser Ser
C16H29N5O9 (435.19651840000006)
Lys Gly Met Thr
Lys Gly Thr Met
Lys Met Ala Ser
Lys Met Gly Thr
Lys Met Ser Ala
Lys Met Thr Gly
Lys Ser Ala Met
Lys Ser Cys Val
Lys Ser Asp Ser
C16H29N5O9 (435.19651840000006)
Lys Ser Met Ala
Lys Ser Ser Asp
C16H29N5O9 (435.19651840000006)
Lys Ser Thr Thr
Lys Ser Val Cys
Lys Thr Gly Met
Lys Thr Met Gly
Lys Thr Ser Thr
Lys Thr Thr Ser
Lys Val Cys Ser
Lys Val Ser Cys
Met Ala Lys Ser
Met Ala Ser Lys
Met Gly Lys Thr
Met Gly Thr Lys
Met Lys Ala Ser
Met Lys Gly Thr
Met Lys Ser Ala
Met Lys Thr Gly
Met Ser Ala Lys
Met Ser Lys Ala
Met Thr Gly Lys
Met Thr Lys Gly
Asn Phe Gly Val
Asn Phe Val Gly
Asn Gly Phe Val
Asn Gly Val Phe
Asn Thr Thr Thr
C16H29N5O9 (435.19651840000006)
Asn Val Phe Gly
Asn Val Gly Phe
Gln Ala Ala Phe
Gln Ala Phe Ala
Gln Phe Ala Ala
Gln Ser Thr Thr
C16H29N5O9 (435.19651840000006)
Gln Thr Ser Thr
C16H29N5O9 (435.19651840000006)
Gln Thr Thr Ser
C16H29N5O9 (435.19651840000006)
Arg Ala Cys Ser
C15H29N7O6S (435.18999340000005)
Arg Ala Ser Cys
C15H29N7O6S (435.18999340000005)
Arg Cys Ala Ser
C15H29N7O6S (435.18999340000005)
Arg Cys Gly Thr
C15H29N7O6S (435.18999340000005)
Arg Cys Ser Ala
C15H29N7O6S (435.18999340000005)
Arg Cys Thr Gly
C15H29N7O6S (435.18999340000005)
Arg Phe Gly Gly
C19H29N7O5 (435.22300640000003)
Arg Gly Cys Thr
C15H29N7O6S (435.18999340000005)
Arg Gly Phe Gly
C19H29N7O5 (435.22300640000003)
Arg Gly Gly Phe
C19H29N7O5 (435.22300640000003)
Arg Gly Thr Cys
C15H29N7O6S (435.18999340000005)
Arg Ser Ala Cys
C15H29N7O6S (435.18999340000005)
Arg Ser Cys Ala
C15H29N7O6S (435.18999340000005)
Arg Ser Ser Ser
Arg Thr Cys Gly
C15H29N7O6S (435.18999340000005)
Arg Thr Gly Cys
C15H29N7O6S (435.18999340000005)
Ser Ala Cys Arg
C15H29N7O6S (435.18999340000005)
Ser Ala Lys Met
Ser Ala Met Lys
Ser Ala Arg Cys
C15H29N7O6S (435.18999340000005)
Ser Cys Ala Arg
C15H29N7O6S (435.18999340000005)
Ser Cys Lys Val
Ser Cys Arg Ala
C15H29N7O6S (435.18999340000005)
Ser Cys Val Lys
Ser Asp Lys Ser
C16H29N5O9 (435.19651840000006)
Ser Asp Ser Lys
C16H29N5O9 (435.19651840000006)
Ser Lys Ala Met
Ser Lys Cys Val
Ser Lys Asp Ser
C16H29N5O9 (435.19651840000006)
Ser Lys Met Ala
Ser Lys Ser Asp
C16H29N5O9 (435.19651840000006)
Ser Lys Thr Thr
Ser Lys Val Cys
Ser Met Ala Lys
Ser Met Lys Ala
Ser Gln Thr Thr
C16H29N5O9 (435.19651840000006)
Ser Arg Ala Cys
C15H29N7O6S (435.18999340000005)
Ser Arg Cys Ala
C15H29N7O6S (435.18999340000005)
Ser Arg Ser Ser
Ser Ser Asp Lys
C16H29N5O9 (435.19651840000006)
Ser Ser Lys Asp
C16H29N5O9 (435.19651840000006)
Ser Ser Arg Ser
Ser Ser Ser Arg
Ser Thr Lys Thr
Ser Thr Gln Thr
C16H29N5O9 (435.19651840000006)
Ser Thr Thr Lys
Ser Thr Thr Gln
C16H29N5O9 (435.19651840000006)
Ser Val Cys Lys
Ser Val Lys Cys
Thr Cys Gly Arg
C15H29N7O6S (435.18999340000005)
Thr Cys Arg Gly
C15H29N7O6S (435.18999340000005)
Thr Gly Cys Arg
C15H29N7O6S (435.18999340000005)
Thr Gly Lys Met
Thr Gly Met Lys
Thr Gly Arg Cys
C15H29N7O6S (435.18999340000005)
Thr Lys Gly Met
Thr Lys Met Gly
Thr Lys Ser Thr
Thr Lys Thr Ser
Thr Met Gly Lys
Thr Met Lys Gly
Thr Asn Thr Thr
C16H29N5O9 (435.19651840000006)
Thr Gln Ser Thr
C16H29N5O9 (435.19651840000006)
Thr Gln Thr Ser
C16H29N5O9 (435.19651840000006)
Thr Arg Cys Gly
C15H29N7O6S (435.18999340000005)
Thr Arg Gly Cys
C15H29N7O6S (435.18999340000005)
Thr Ser Lys Thr
Thr Ser Gln Thr
C16H29N5O9 (435.19651840000006)
Thr Ser Thr Lys
Thr Ser Thr Gln
C16H29N5O9 (435.19651840000006)
Thr Thr Lys Ser
Thr Thr Asn Thr
C16H29N5O9 (435.19651840000006)
Thr Thr Gln Ser
C16H29N5O9 (435.19651840000006)
Thr Thr Ser Lys
Thr Thr Ser Gln
C16H29N5O9 (435.19651840000006)
Thr Thr Thr Asn
C16H29N5O9 (435.19651840000006)
Val Cys Lys Ser
Val Cys Ser Lys
Val Phe Gly Asn
Val Phe Asn Gly
Val Gly Phe Asn
Val Gly Asn Phe
Val Lys Cys Ser
Val Lys Ser Cys
Val Asn Phe Gly
Val Asn Gly Phe
Val Ser Cys Lys
Val Ser Lys Cys
CAY10585
C26H29NO5 (435.20456240000004)
LW6 (HIF-1α inhibitor) is a novel HIF-1 inhibitor with an IC50 of 4.4 μM. LW6 decreases HIF-1α protein expression without affecting HIF-1β expression.
Cadabicine
C25H29N3O4 (435.21579540000005)
7-Hydroxy-13-deoxypaxilline
nomega-(2-acetamido-2-deoxy-beta-d-glucopyranosyl)-nalpha-(tert-butoxycarbonyl)-l-asparagine
(3R,5S,E)-METHYL 7-(2-CYCLOPROPYL-4-(4-FLUOROPHENYL)QUINOLIN-3-YL)-3,5-DIHYDROXYHEPT-6-ENOATE
C26H26FNO4 (435.18457680000006)
Thieno[2,3-b]quinoline-2-carboxamide, N-cyclopentyl-N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl- (9CI)
C25H29N3O2S (435.19803740000003)
DANSYL-GAMMA-AMINO-N-BUTYRIC ACID CYCLOHEXYLAMMONIUM SALT
C22H33N3O4S (435.2191658000001)
N-(1-L-Phenylalanine)-4-(1-pyrene)butyramide
C29H25NO3 (435.18343400000003)
4-NITROPHENYL PHOSPHATE DI(CYCLOHEXYLAMINE) SALT MONOHYDRATE
4-Nitrophenyl phosphate,bis(cyclohexylammonium) salt hydrate
OPIPRAMOL DIHYDROCHLORIDE
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
1-(S)- CIS 9-AMINOOCTAHYDRO-10-OXO-6H-PYRIDAZINO[1,2-A][1,2]DIAZEPINE-1-CARBOXYLIC ACID, T-BUTYL ESTER
C22H33N3O6 (435.23692380000006)
(3R,4R)-N-Hydroxy-4-({4-[(2-methyl-4-quinolinyl)methoxy]benzoyl}a mino)tetrahydro-2H-pyran-3-carboxamide
2,4-Diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine
2,4-Diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine
2-[1-[2-(diethylamino)-2-oxoethyl]-3-indolyl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxoacetamide
2-Acetoxy-1-acetyl-3,6-di(tert-butylthio)-4-phenyl-1,2,3,6-tetrahydropyridine
C23H33NO3S2 (435.1901748000001)
2-{4-[4-({4-[2-Methyl-1-(1-Methylethyl)-1h-Imidazol-5-Yl]pyrimidin-2-Yl}amino)phenyl]piperazin-1-Yl}-2-Oxoethanol
TRIMAZOSIN
C - Cardiovascular system > C02 - Antihypertensives > C02C - Antiadrenergic agents, peripherally acting > C02CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
[4-(Phenylmethyl)piperidin-1-Yl]-[1-(5-Pyrrol-1-Yl-1,3,4-Thiadiazol-2-Yl)piperidin-4-Yl]methanone
C24H29N5OS (435.20927040000004)
3beta,14beta-dihydroxy-5beta-pregnane-20-one-21-O-malonylhemiester
[(1S)-2-[2-[(2R,3R,4S,5R,6R)-6-[(1R,2R)-1-amino-2-hydroxypropyl]-3,4,5-trihydroxyoxan-2-yl]sulfanyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium
(22Z)-4-hydroxy-2-oxa-11,16,20-triazatricyclo[22.2.2.13,7]nonacosa-1(26),3,5,7(29),8,22,24,27-octaene-10,21-dione
C25H29N3O4 (435.21579540000005)
6-methoxy-3-[[[1-(2-methoxyethyl)-5-tetrazolyl]methyl-(3-pyridinylmethyl)amino]methyl]-1H-quinolin-2-one
C22H25N7O3 (435.20187799999997)
1-(4-ethoxyphenyl)-5-[2-methyl-4-(4-morpholinyl)benzylidene]-2,4,6(1H,3H,5H)-pyrimidinetrione
N,N-dibutyl-2-[[2-(1,3-dioxo-2-isoindolyl)-1-oxoethyl]amino]benzamide
C25H29N3O4 (435.21579540000005)
Methyl 3-{2-[4-(adamantan-2-YL)phenoxy]acetamido}-4-hydroxybenzoate
C26H29NO5 (435.20456240000004)
2-Cyclopentyl-4-[1,4-dioxa-8-azaspiro[4.5]decan-8-yl(oxo)methyl]-9-methyl-1-pyrido[3,4-b]indolone
C25H29N3O4 (435.21579540000005)
4-[2,2-bis(1-phenyl-5-tetrazolyl)ethenyl]-N,N-dimethylaniline
N-(2-furanylmethyl)-N-[4-methyl-2-(4-methyl-1-piperazinyl)-6-quinolinyl]butanediamide
(2E)-N-(11-oxo-6,8,9,11-tetrahydro-7H-pyrido[2,1-b]quinazolin-2-yl)-3-(3,4,5-trimethoxyphenyl)acrylamide
[1-[3-(4-Chlorophenoxy)propyl]-4-piperidinyl]-diphenylmethanol
(1S,9R,10R,11R)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H29N3O4 (435.21579540000005)
N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
[(1S)-1-(cyclopropylmethyl)-2-[(2-fluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
1-[(2S,3R)-2-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(3-pyridinyl)ethanone
C25H29N3O4 (435.21579540000005)
(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
[(1R)-1-(cyclopropylmethyl)-2-[(2-fluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(4S,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
N-[(5S,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
C22H33N3O6 (435.23692380000006)
(3R,6aS,8S,10aS)-8-[2-(cyclobutylamino)-2-oxoethyl]-N-(4-fluorophenyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H29N3O4 (435.21579540000005)
(6R,7R,8S)-7-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-[(2-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C25H29N3O4 (435.21579540000005)
1-[(2S,3S)-2-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(3-pyridinyl)ethanone
C25H29N3O4 (435.21579540000005)
1-[(2R,3R)-2-(hydroxymethyl)-1-[4-oxanyl(oxo)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-2-(3-pyridinyl)ethanone
C25H29N3O4 (435.21579540000005)
(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-N-(4-fluorophenyl)-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8S)-N-(3-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-(4-pent-1-ynylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[(2-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C25H29N3O4 (435.21579540000005)
2-[Bis(phenylmethyl)amino]-1-(4-phenylmethoxyphenyl)-1-propanone
(3E,5S)-3-[(2E,4E,8S,10E,12Z)-1-hydroxy-4,8-dimethyltetradeca-2,4,10,12-tetraenylidene]-5-[(4-hydroxyphenyl)methyl]pyrrolidine-2,4-dione
N-Pentanoyl-N-{[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
NA-Taurine 22:6(4Z,7Z,10Z,13Z,16Z,19Z)
C24H37NO4S (435.24431620000007)
(1s,9r,11s,14e)-11,15-dihydroxy-14-(3h-imidazol-4-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,15-tetraen-12-one
n-[2-(4-{[(2e)-4-(acetyloxy)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid
ancistrobertsoine B
{"Ingredient_id": "HBIN015983","Ingredient_name": "ancistrobertsoine B","Alias": "NA","Ingredient_formula": "C27H33NO4","Ingredient_Smile": "CC1CC2=C(C(=CC(=C2C(N1C)C)OC)OC)C3=C4C=CC=C(C4=C(C=C3C)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35975","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
ancistrobertsonine C
{"Ingredient_id": "HBIN015985","Ingredient_name": "ancistrobertsonine C","Alias": "NA","Ingredient_formula": "C27H33NO4","Ingredient_Smile": "CC1CC2=C(C(=CC(=C2C(N1C)C)OC)OC)C3=C4C=C(C=C(C4=C(C=C3)OC)OC)C","Ingredient_weight": "435.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32450","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10410728","DrugBank_id": "NA"}
ancistrobrevin
{"Ingredient_id": "HBIN015987","Ingredient_name": "ancistrobrevin","Alias": "NA","Ingredient_formula": "C27H33NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(N1C)C)OC)C3=C4C=C(C=C(C4=C(C=C3)OC)OC)C)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33058","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,3r)-5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-6,8-dimethoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinoline
5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-2-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-3h-isoindol-1-one
7-[2-(5-amino-2,2-dimethylchromen-6-yl)-2-oxoethyl]-9-hydroxy-11-(prop-1-en-2-yl)-5,8-diazatricyclo[5.2.2.0¹,⁵]undec-8-en-6-one
C25H29N3O4 (435.21579540000005)
5-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-2-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-3h-isoindol-1-one
11-hydroxy-14-(1h-imidazol-4-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7-triene-12,15-dione
2-({1,2-bis[(2-hydroxyphenyl)methyl]indol-3-yl}methyl)phenol
C29H25NO3 (435.18343400000003)
(22z)-2-oxa-11,16,20-triazatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3(29),4,6,8,10,20,22,24,27-decaene-4,10,21-triol
C25H29N3O4 (435.21579540000005)
9-hydroxy-4,5-dimethoxy-16-oxa-23-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁸,²³]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
(8e,22e)-2-oxa-11,16,20-triazatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3(29),4,6,8,10,20,22,24,27-decaene-4,10,21-triol
C25H29N3O4 (435.21579540000005)
(10e)-11-[5-({[(3s)-3-carboxy-1-hydroxy-3-methylpropylidene]amino}carbonyl)-4-oxopyran-2-yl]undec-10-enoic acid
(1r,9s,14e)-11,15-dihydroxy-14-(3h-imidazol-4-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,15-tetraen-12-one
(1s,2s,5s,7r,11r,14s)-5-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one
(1r,7r,11r)-7-[2-(5-amino-2,2-dimethylchromen-6-yl)-2-oxoethyl]-9-hydroxy-11-(prop-1-en-2-yl)-5,8-diazatricyclo[5.2.2.0¹,⁵]undec-8-en-6-one
C25H29N3O4 (435.21579540000005)
(1s,13e,17r,19r)-9-hydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
(1r,9s,11r,14e)-11,15-dihydroxy-14-(3h-imidazol-4-ylmethylidene)-2-methoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,15-tetraen-12-one
3-methoxy-6-{2-[2-methyl-5-(prop-1-en-2-yl)oxolan-2-yl]ethenyl}-4-phenyl-3h-quinoline-2,4,5-triol
C26H29NO5 (435.20456240000004)
(1's,2r,2's,3r,3's,4r,6'r)-3'-ethyl-1',3-dihydroxy-4-methyl-11'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5'-oxa-10'-azaspiro[oxolane-2,4'-tricyclo[8.3.0.0²,⁶]tridecan]-11'-ene-5,13'-dione
2,4-dimethyl-4-[2-(2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl)ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
(1s,3s)-5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-6,8-dimethoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinoline
(2r,4s)-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
(1s,7r,7ar)-7-({[(2s,3r)-3-(acetyloxy)-2-hydroxy-2-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate
(2e,6e)-8-[4,6-dihydroxy-1-oxo-2-(2-phenylethyl)-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid
C26H29NO5 (435.20456240000004)
8-[4,6-dihydroxy-1-oxo-2-(2-phenylethyl)-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid
C26H29NO5 (435.20456240000004)
(1s,13z,17s,19s)-9-hydroxy-5,6-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2,4,6,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
(3s,5s)-5-[(3s,8s,9r,9as)-8-hydroxy-9-[(2s)-1-(5-hydroxy-3-methoxy-4-methylfuran-2-yl)-1-oxopropan-2-yl]-octahydro-1h-pyrrolo[1,2-a]azepin-3-yl]-3-methyloxolan-2-one
C23H33NO7 (435.22569080000005)
5-({1,4-bis[(4-methoxyphenyl)methyl]imidazol-2-yl}amino)-2-hydroxy-3-methyl-5h-imidazol-4-one
2-oxa-11,16,20-triazatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3(29),4,6,8,10,20,22,24,27-decaene-4,10,21-triol
C25H29N3O4 (435.21579540000005)
2-[(5-{[(1r,2s,4as,8as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]ethanesulfonic acid
C23H33NO5S (435.2079328000001)
(1's,2s,2's,3r,3's,4r,6'r)-3'-ethyl-1',3-dihydroxy-4-methyl-11'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5'-oxa-10'-azaspiro[oxolane-2,4'-tricyclo[8.3.0.0²,⁶]tridecan]-11'-ene-5,13'-dione
9-hydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one
C26H29NO5 (435.20456240000004)
(1r,3s)-5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-6,8-dimethoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinoline
11-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one
2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
11-(5-{[(3-carboxy-1-hydroxy-3-methylpropylidene)amino]carbonyl}-4-oxopyran-2-yl)undec-10-enoic acid
(5z)-5-{1-hydroxy-2-[8-hydroxy-3-(4-methyl-5-oxooxolan-2-yl)-octahydro-1h-pyrrolo[1,2-a]azepin-9-yl]propylidene}-4-methoxy-3-methylfuran-2-one
C23H33NO7 (435.22569080000005)
(2s,4r)-2,4-dimethyl-4-[(1e)-2-[(3s,4s)-2,4,5-trihydroxy-3-methoxy-4-phenyl-3h-quinolin-6-yl]ethenyl]cyclohexan-1-one
C26H29NO5 (435.20456240000004)
(3s,4s)-3-methoxy-6-[(1e)-2-[(2r,5r)-2-methyl-5-(prop-1-en-2-yl)oxolan-2-yl]ethenyl]-4-phenyl-3h-quinoline-2,4,5-triol
C26H29NO5 (435.20456240000004)